Top compounds associated with response to TBC1D16


Feature Type Standardized
Nominal ANOVA
mRNA lenalidomide GDSC1000 pan-cancer AAC -0.076 0.09
mRNA Y-39983 GDSC1000 pan-cancer AAC -0.067 0.09
mRNA Docetaxel CTRPv2 pan-cancer AAC -0.091 0.09
mRNA momelotinib CTRPv2 pan-cancer AAC -0.067 0.09
mRNA etoposide GDSC1000 pan-cancer AAC -0.073 0.09
mRNA Tamoxifen GDSC1000 pan-cancer AAC -0.071 0.09
mRNA Dasatinib GDSC1000 pan-cancer AAC -0.099 0.1
mRNA GDC-0941 gCSI pan-cancer AAC -0.13 0.1
mRNA shikonin GDSC1000 pan-cancer AAC -0.07 0.1
mRNA TPCA-1 GDSC1000 pan-cancer AAC -0.059 0.1
Download CSV